Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-Label Tiotropium Bromide and Placebo in Mild-to-Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients.
This study has been completed.
Study NCT00568503.
Last updated on March 7, 2008.
Information provided by Novartis
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
